Seoul National University Bundang Hospital (SNUBH) Case: Unexplained Opsoclonus Myoclonus
Ataxia (Rapid involuntary eye movement and muscle twitch and body imbalance)
Kate was diagnosed with Opsoclonus Myoclonus
Syndrome in 2017 and is currently undergoing treatment, including blood transfusions, every month.
Diagnostic and demographic details of the patients treated with plasmapheresis Diagnosis Number Mean age [+ or -] SD Sex of the (Female/ patients Male) GBS 60 52.5 [+ or -] 15.86 27/33 CIDP 4 49.3 [+ or -] 17 2/2 MG (prethymectomy) 9 41.1 [+ or -] 18.8 5/4 MC 14 51.6 [+ or -] 15.6 3/11 ADEM 1 28 0/1 Septic Encephalopathy 1 18 1/0 Polymyositis 1 51 0/1 OMS 1 49 0/1 GBS: Guillain Barre Syndrome, CIDP: Chronic Inflammatory Demyelinating Polyneuropathy, MG: Myasthenia Gravis, MC: Myasthenic Crisis, ADEM: Acute Disseminated Encephalomyelitis, OMS: Opsoclonus Myoclonus
Syndrome Table 2.
On April 24th, 2013, Baby Jonathan "Tell" was diagnosed with Opsoclonus Myoclonus
Ataxia Syndrome (OMS) at the young age of 20 months old.
Acthar Gel is an injectable drug that is approved for the treatment of exacerbations associated with multiple sclerosis, infantile spasms, opsoclonus myoclonus
syndrome, and nephrotic syndrome.